Analysis of Serum Level of HE4 and CA125 Considering Selected Risk Factors Among Patients With Endometrioid Endometrial Cancer

Wspolczesna Onkologia - Poland
doi 10.5114/wo.2016.65606
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Termedia Sp. z.o.o.

Related search

Serum HE4 Detects Recurrent Endometrial Cancer in Patients Undergoing Routine Clinical Surveillance

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Nodal Metastasis Risk in Endometrioid Endometrial Cancer

Obstetrics and Gynecology
GynecologyObstetrics
2012English

Diagnostic and Prognostic Impact of Serum HE4 Detection in Endometrial Carcinoma Patients

British Journal of Cancer
Cancer ResearchOncology
2011English

The Clinical Significance of DJ-1 and HE4 in Patients With Endometrial Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2017English

Ovarian Volumes Among Women With Endometrial Carcinoma: Associations With Risk Factors and Serum Hormones

Gynecologic Oncology
GynecologyOncologyObstetrics
2007English

Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Association of miRNA-200c Expression Levels With Clinicopathological Factors and Prognosis in Endometrioid Endometrial Cancer

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
2018English

Use of a Symptom Index, CA125, and HE4 to Predict Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2010English

An Exploratory Analysis of Γ-Synuclein Expression in Endometrioid Endometrial Cancer

BMJ Open
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy